The Rapid Surface Ag 2019-nCov is a rapid test for the detection of SARS-CoV-2 Nucleocapsid Protein Antigen (NP) in swabs of common surfaces, such as metal, plastic, glass, paper, and stainless steel. It is the first product for COVID-19 surface testing to utilize this innovative methodology. The Rapid Surface Ag 2019-nCov is a valuable tool for several sectors enabling the companies to monitor and mitigate the spread of COVID-19 in their facilities and maintain a safe operating environment.
Rapid Test Ag 2019-nCov is a lateral flow test with high sensitivity for the detection of SARS-CoV-2 antigen (nucleocapsid protein) in nasal or nasopharyngeal swab specimens. It helps to rapidly identify infected individuals, enabling prompt clinical decisions and preventing a potential virus outbreak. The test does not require any special instrument and can be used in all types of premises.
Semi-quantitative ELISA test of 48 or 96 wells quantifying IgA, IgM, IgG antibodies against SARS-CoV-2 in human serum or plasma (Heparin, EDTA or Citrate) specimens.
Purification of DNA and/or RNA: for DNA and RNA from cell-free media (serum, plasma, body fluids and the supernatant from viral infected cell cultures)
Semi-quantitative ELISA test of 48 or 96 wells quantifying IgM antibodies against SARS-CoV-2 in human serum or plasma (Heparin, EDTA or Citrate) specimens.
0.8784598112106323
Cookies help us deliver our services. By using our services, you agree to our use of cookies.